These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1864013)

  • 1. Interleukin-2 receptor gene expression in kidney transplant recipients treated with cyclosporin A.
    Yoshimura N; Oka T; Amagai T; Horii Y; Imanishi J
    Clin Exp Immunol; 1991 Aug; 85(2):326-30. PubMed ID: 1864013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination therapy of cyclosporine with steroid inhibits gamma-interferon and interleukin-1 gene expression at the level of mRNA synthesis in vivo.
    Yoshimura N; Oka T; Kita M; Teraoka H; Hirai Y
    J Clin Immunol; 1989 Jul; 9(4):322-8. PubMed ID: 2504764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of combination therapy of cyclosporine with steroid on the production of gamma-interferon and interleukin-1 in kidney transplant recipients].
    Yoshimura N; Oka T; Hamashima T; Lee CJ; Ohsaka Y; Hirakawa K
    Nihon Geka Gakkai Zasshi; 1990 Aug; 91(8):1011-5. PubMed ID: 2122226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of dialysis patients' lymphocyte IL-2R expression by glucocorticoids and cyclosporine.
    Briggs WA; Gao ZH; Xing JJ; Scheel PJ; Gimenez LF; Samaniego MD; Choi MJ; Burdick JF
    Cytokine; 1997 Aug; 9(8):624-8. PubMed ID: 9245491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporin A inhibits the interleukin 2 receptor alpha chain gene transcription but not its cell surface expression: the alpha chain stability can explain this discrepancy.
    Hémar A; Dautry-Varsat A
    Eur J Immunol; 1990 Dec; 20(12):2629-35. PubMed ID: 2269327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamic assessment of the in vivo cyclosporine effect on interleukin-2 production by lymphocytes in kidney transplant recipients.
    Yoshimura N; Kahan BD
    Transplantation; 1985 Dec; 40(6):661-6. PubMed ID: 3934806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutive and mitogen-stimulated cytokine mRNA expression by peripheral blood mononuclear cells from most autologous and allogeneic bone marrow transplant recipients is intact.
    Lum LG; Joshi ID; Smith MR; Ratanatharathorn V; Galoforo SC; Karanes C; Uberti JP; Sensenbrenner LL
    Bone Marrow Transplant; 1994 Feb; 13(2):187-95. PubMed ID: 8205088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mixed lymphocyte reaction-induced release of soluble IL-2 receptor.
    Degiannis D; Czarnecki M; Hornung N; Raskova J; Raska K
    Transplantation; 1991 Feb; 51(2):518-23. PubMed ID: 1825248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of IL 2R+ T cells and macrophages within rejecting rat cardiac allografts, and comparison of the effects of treatment with anti-IL 2R monoclonal antibody or cyclosporin.
    Hancock WW; Lord RH; Colby AJ; Diamantstein T; Rickles FR; Dijkstra C; Hogg N; Tilney NL
    J Immunol; 1987 Jan; 138(1):164-70. PubMed ID: 3097143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cyclosporin A on DNA repair and cancer incidence in kidney transplant recipients.
    Herman M; Weinstein T; Korzets A; Chagnac A; Ori Y; Zevin D; Malachi T; Gafter U
    J Lab Clin Med; 2001 Jan; 137(1):14-20. PubMed ID: 11150019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo action of cyclosporin A on the induction of human interleukin-2 receptor alpha and beta chains.
    Caillat-Zucman S; Chatenoud L; Bach JF
    Clin Exp Immunol; 1989 Aug; 77(2):184-90. PubMed ID: 2789115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The inhibition of interleukin 2 (IL-2) receptor gene expression in kidney transplant recipients treated with ciclosporin: preliminary report].
    Yoshimura N; Oka T
    Nihon Geka Gakkai Zasshi; 1989 Jun; 90(6):956. PubMed ID: 2796968
    [No Abstract]   [Full Text] [Related]  

  • 13. Altered interleukin-2 receptor alpha-chain is expressed in human T-cell leukaemia virus type-I-infected T-cell lines and human peripheral blood mononuclear cells of adult T-cell leukaemia patients through an alternative splicing mechanism.
    Horiuchi S; Koyanagi Y; Tanaka Y; Waki M; Matsumoto A; Zhou YW; Yamamoto M; Yamamoto N
    Immunology; 1997 May; 91(1):28-34. PubMed ID: 9203962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The in vivo effect of cyclosporine on interleukin-6 gene expression in renal transplant recipients.
    Yoshimura N; Kahan BD; Oka T
    Transplant Proc; 1991 Feb; 23(1 Pt 2):958-60. PubMed ID: 1989345
    [No Abstract]   [Full Text] [Related]  

  • 15. Expression of interleukin-2 receptor alpha (IL-2R alpha) mRNA and protein in advanced epithelial ovarian cancer.
    Barton DP; Blanchard DK; Wells AF; Nicosia SV; Roberts WS; Cavanagh D; Djeu JY
    Anticancer Res; 1994; 14(3A):761-72. PubMed ID: 8074478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment with cyclosporine and anti-interleukin 2 receptor antibody abrogates the anti-idiotype response in rat recipients of cardiac allografts.
    Tanaka K; Tilney NL; Stunkel KG; Hancock WW; Diamantstein T; Kupiec-Weglinski JW
    Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7375-9. PubMed ID: 2217171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporin A inhibits induction of IL-2 receptor alpha chain expression by affecting activation of NF-kB-like factor(s) in cultured human T lymphocytes.
    Brini AT; Harel-Bellan A; Farrar WL
    Eur Cytokine Netw; 1990; 1(3):131-9. PubMed ID: 2129797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-CD3 antibody-induced expression of both p55 and p75 chains of the high affinity interleukin-2 receptor on human T lymphocytes is inhibited by cyclosporin A.
    Foxwell BM; Simon J; Herrero JJ; Taylor D; Woerly G; Cantrell D; Ryffel B
    Immunology; 1990 Jan; 69(1):104-9. PubMed ID: 2312149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential IL-2 receptor expression in renal allograft recipients treated with an anti-IL-2-receptor antibody.
    Ramos EL; Milford EL; Kirkman RL; Tilney NL; Strom TB; Shapiro ME; Waldmann TA; Wood IG; Rollins MR; Carpenter CB
    Transplantation; 1989 Sep; 48(3):415-20. PubMed ID: 2571203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of immunosuppressive effects of cyclosporin A by 1 alpha,25-dihydroxyvitamin D3.
    Gupta S; Fass D; Shimizu M; Vayuvegula B
    Cell Immunol; 1989 Jul; 121(2):290-7. PubMed ID: 2786759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.